Amylyx Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (AMLX)

Historical Holders from Q1 2022 to Q1 2025

Symbol
AMLX on Nasdaq
CUSIP
03237H101
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
84.6M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
49.8M
Holdings value
$188M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
122
Number of buys
59
Number of sells
-58
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Amylyx Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (AMLX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 7.9% $23.6M 6.77M Perceptive Advisors LLC Dec 31, 2024
Point72 Asset Management, L.P. 5.6% $16.8M 4.82M Point72 Asset Management, L.P. Jan 13, 2025
Panacea Innovation Ltd 2.6% $7.68M 2.2M Panacea Venture Healthcare Fund II, L.P. Dec 31, 2024

Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (AMLX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 130K $460K +$6.53K $3.54 4
2024 Q4 49.8M $188M +$19.5M $3.78 122
2024 Q3 43.4M $141M +$5.13M $3.24 109
2024 Q2 43.6M $82.9M -$16.9M $1.90 119
2024 Q1 49.5M $141M -$233M $2.84 145
2023 Q4 60.3M $887M -$52.5M $14.72 177
2023 Q3 58.9M $1.08B +$85.4M $18.31 168
2023 Q2 54.5M $1.17B +$53.6M $21.57 152
2023 Q1 51.4M $1.51B +$73.7M $29.34 145
2022 Q4 48.5M $1.79B +$430M $36.95 130
2022 Q3 36.6M $1.03B +$308M $28.15 88
2022 Q2 26.6M $513M +$61.9M $19.26 73
2022 Q1 23.3M $299M +$299M $12.85 70